Latest news in Uterine Fibroids
BioSphere Medical to Present at the Wall Street Analyst Forum Conference (Centre Daily Times)
28 Aug 2008
BioSphere Medical, Inc. (NASDAQ:BSMD) ("BioSphere") - a medical device company that has pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy - announced today that Martin Joyce, executive vice president and chief financial officer, is scheduled to ...28 Aug 2008
ROCKLAND, Mass.----BioSphere Medical, Inc. - a medical device company that has pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy - announced today that Martin Joyce, executive vice president and chief financial officer, is scheduled to present ...27 Aug 2008
Scientific abstracts, covering all areas of vascular and nonvascular interventional radiology, are being accepted for the 2009 Society of Interventional Radiology's Annual Scientific Meeting in San Diego, Calif. Online abstract submission began in July for original scientific material for oral or poster presentations. The deadline for abstract submission deadline is Oct. 7.In this category: Websites: 0, Number of pages: 0, Last updated: 30 Aug 2008
